Xoma | XOMA - Ordinary Share Capital

Stock Price
26.38
Daily Change
-0.48 -1.79%
Monthly
7.81%
Yearly
29.09%
Q1 Forecast
25.58

Xoma reported $87K in Ordinary Share Capital for its fiscal quarter ending in June of 2024.





Ordinary Share Capital Change Date
AbbVie USD 1.77B 1.75B Jun/2025
Agenus USD 266K 30K Mar/2025
Agios Pharmaceuticals USD 58.45M 169K Dec/2025
Ardelyx USD 238.02M 1.13M Dec/2024
aTyr Pharma USD 97.99M 97.9M Sep/2025
BioMarin Pharmaceutical USD 192.3M 201K Dec/2025
Celldex Therapeutics USD 66.55M 102K Dec/2025
Curis USD 59K 934K Sep/2023
Eli Lilly USD 946.83M 354.23M Jun/2025
Emergent BioSolutions USD 100K 0 Jun/2023
Incyte USD 198.46M 2.33M Dec/2025
MacroGenics USD 63.26M 62.63M Sep/2025
Novartis USD 1.94B 23.4M Jun/2025
Novartis USD 1.92B 17.06M Sep/2025
Pfizer USD 5.69B 1000K Sep/2025
Prothena USD 53.83M 53.29M Sep/2025
Regeneron Pharmaceuticals USD 105.3M 1.1M Sep/2025
Xoma USD 87K 1000 Jun/2024